The global medical devices market size is calculated at USD 678.88 billion in 2025 and is expected to reach around USD 1,146.95 billion by 2034, expanding at a CAGR of 6% from 2025 to 2034. The North America medical devices market size reached USD 256.18 billion in 2024 and is expanding at a CAGR of 6.05% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Devices Market Revenue and Volume, By TypeEnd-user
8.1.1 Diagnostic Imaging
8.1.1.1. Market Revenue and Volume Forecast End-user
8.1.2. Orthopedic Devices
8.1.2.1. Market Revenue and Volume Forecast End-user
8.1.3. Cardiovascular Devices
8.1.3.1. Market Revenue and Volume Forecast End-user
8.1.4. Minimally Invasive Surgical (MIS)
8.1.4.1. Market Revenue and Volume Forecast End-user
8.1.5. Wound Management
8.1.5.1. Market Revenue and Volume Forecast End-user
8.1.6. Diabetes Care
8.1.6.1. Market Revenue and Volume Forecast End-user
8.1.7. Ophthalmic Devices
8.1.7.1. Market Revenue and Volume Forecast End-user
8.1.8. General Surgery
8.1.8.1. Market Revenue and Volume Forecast End-user
8.1.9. Dental Devicess
8.1.9.1. Market Revenue and Volume Forecast End-user
8.1.10. In Vitro Diagnostics (IVD)
8.1.10.1. Market Revenue and Volume Forecast End-user
8.1.11. Others
8.1.11.1. Market Revenue and Volume Forecast End-user
9.1. Medical Devices Market Revenue and Volume, By End-userEnd-user
9.1.1. Hospitals & Ambulatory Surgery Centers (ASCs)
9.1.1.1. Market Revenue and Volume Forecast End-user
9.1.2. Clinics
9.1.2.1. Market Revenue and Volume Forecast End-user
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast End-user
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Type End-user
10.1.2. Market Revenue and Volume Forecast, By End-user End-user
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Type End-user
10.1.3.2. Market Revenue and Volume Forecast, By End-user End-user
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Type End-user
10.1.4.2. Market Revenue and Volume Forecast, By End-user End-user
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Type End-user
10.2.2. Market Revenue and Volume Forecast, By End-user End-user
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Type End-user
10.2.3.2. Market Revenue and Volume Forecast, By End-user End-user
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Type End-user
10.2.4.2. Market Revenue and Volume Forecast, By End-user End-user
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Type End-user
10.2.5.2. Market Revenue and Volume Forecast, By End-user End-user
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Type End-user
10.2.6.2. Market Revenue and Volume Forecast, By End-user End-user
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Type End-user
10.3.2. Market Revenue and Volume Forecast, By End-user End-user
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Type End-user
10.3.3.2. Market Revenue and Volume Forecast, By End-user End-user
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Type End-user
10.3.4.2. Market Revenue and Volume Forecast, By End-user End-user
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Type End-user
10.3.5.2. Market Revenue and Volume Forecast, By End-user End-user
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Type End-user
10.3.6.2. Market Revenue and Volume Forecast, By End-user End-user
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Type End-user
10.4.2. Market Revenue and Volume Forecast, By End-user End-user
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Type End-user
10.4.3.2. Market Revenue and Volume Forecast, By End-user End-user
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Type End-user
10.4.4.2. Market Revenue and Volume Forecast, By End-user End-user
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Type End-user
10.4.5.2. Market Revenue and Volume Forecast, By End-user End-user
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Type End-user
10.4.6.2. Market Revenue and Volume Forecast, By End-user End-user
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Type End-user
10.5.2. Market Revenue and Volume Forecast, By End-user End-user
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Type End-user
10.5.3.2. Market Revenue and Volume Forecast, By End-user End-user
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Type End-user
10.5.4.2. Market Revenue and Volume Forecast, By End-user End-user
11.1. DePuy Synthes
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medtronics Plc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Fesenius Medical Care
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. GE Healthcare
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Philips Healthcare
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Ethicon LLC
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Siemens Healthineers
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Stryker
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Cardinal Health
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Baxter International Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client